全球无针给药装置市场规模、份额、成长分析，按技术（喷射注射器、透皮贴剂）、最终用户（医院和诊所到家庭医疗保健机构）- 2024-2031 年行业预测

2022年全球无针给药装置市场规模为139.9亿美元，预计将从2023年的149.4亿美元增长到2031年的252.9亿美元，预测期内（2024-2031年）CAGR为6.8% 。

全球无针给药装置市场有潜力彻底改变医疗保健产业，标誌着一个重要的成长期。这些设备消除了在给药过程中使用传统针头的情况，从而降低了风险并消除了患者的痛苦。医疗保健产业对无痛给药方法的需求不断增长，特别是对于自体免疫疾病和糖尿病等慢性疾病。这种需求，加上对自我注射药物的需求和不断增加的老年人口，正在推动市场扩张。透皮贴片和喷射注射器等创新技术已经开发出来，由于其精确性和便利性，为市场成长做出了重大贡献。医疗机构在采用这些设备方面一直处于领先地位，以优先考虑患者的舒适度和依从性，儘管家庭护理机构也越来越多地采用这些设备。吸入式药物输送系统以及喷射注射器和透皮贴片等新技术正在进入市场，以满足对患者舒适度和护理的关注所驱动的无针药物输送的需求。然而，高开发成本和监管问题等挑战可能会阻碍市场成长。全球医疗保健产业的不断发展确保了无针给药装置市场的持续扩张，为提高给药效率和改善病患照护提供了潜力。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

按技术分類的全球无针给药装置市场

• 市场概况
• 喷射器
• 透皮贴剂
• 基于吸入的系统

全球无针给药装置市场（依最终用户）

• 市场概况
• 医院和诊所到家庭医疗机构

全球无针给药装置市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2021 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率（%），2021年

主要公司简介

• Becton, Dickinson and Company (BD) (USA)
• Zogenix (USA)
• Pfizer Inc. (USA)
• Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)
• Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)
• PharmaJet (USA)
• 3M (USA)
• National Medical Products Inc. (NMP Pharma) (USA)
• Antares Pharma (USA)
• Crossject (France)
• Novartis AG (Switzerland)
• Bioject Medical Technologies Inc. (USA)
• Pharmajet (USA)
• Astrazeneca (UK)
• Eli Lilly and Company (USA)
• MedImmune (USA, a subsidiary of AstraZeneca)
• Genentech (USA, a subsidiary of Roche)
• Inovio Pharmaceuticals (USA)
• Valeritas (USA)

Global Needle-Free Drug Delivery Devices Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global needle-free drug delivery devices market has the potential to revolutionize the healthcare industry, marking a significant period of growth. These devices eliminate the use of traditional needles in administering medication, thereby reducing risks and eliminating patient pain. There is a growing demand in the healthcare sector for pain-free methods of drug administration, especially for chronic conditions like autoimmune disorders and diabetes. This demand, along with the need for self-injected medications and the rising elderly population, is driving market expansion. Innovative technologies such as transdermal patches and jet injectors have been developed, contributing significantly to market growth due to their precision and convenience. Healthcare facilities have been leading in adopting these devices to prioritize patient comfort and compliance, though homecare settings are also increasingly adopting them. New technologies like inhalable drug delivery systems, along with jet injectors and transdermal patches, are entering the market, meeting the demand for needle-free drug delivery driven by a focus on patient comfort and care. However, challenges such as high development costs and regulatory issues could hinder market growth. The ongoing evolution of the global healthcare sector ensures the continued expansion of the needle-free drug delivery devices market, offering the potential to improve drug delivery efficiency and enhance patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Needle-Free Drug Delivery Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Needle-Free Drug Delivery Devices Market Segmental Analysis

Inhalation-based systems, transdermal patches, and jet injector come under the market segment of technology. The major regions in this market are North America, Europe, and Asia-Pacific. The market's end-users include hospitals, clinics, and home healthcare settings.

Drivers of the Global Needle-Free Drug Delivery Devices Market

Technological Advancements: The market has witnessed the introduction of new, highly efficient devices due to continuous enhancements in needle-free drug delivery technology. This progress has enabled the development of advanced tools such as transdermal patches, micro-needles, and jet injectors. These cutting-edge technologies are applicable across various scenarios, with their precision increasing as technology advances.

Enhanced Patient Comfort and Convenience: Unlike traditional injections, which can be painful and carry infection risks, the needle-free drug delivery devices market offers products that are more convenient and less painful. This has led to a significant increase in their usage. Patients with chronic illnesses, who require frequent drug administration, are increasingly preferring these products over conventional methods. As a result, patients are more comfortable continuing their treatments, leading to improved compliance and better treatment outcomes. This improvement in patient care and adherence is a key driver of market growth.

Restraints in the Global Needle-Free Drug Delivery Devices Market

Regulatory Hurdles: The medical device industry, including needle-free drug delivery products, is subject to stringent regulations. The approval process, essential for patient safety and injection effectiveness, can be prolonged and complex. While necessary, these regulations pose challenges. Complying with standards and awaiting approvals can inflate development costs and postpone production and distribution.

Financial Challenges: Needle-free devices can incur significant expenses compared to traditional syringes. These higher costs may impede adoption, particularly in facilities with limited budgets or scarce financial resources. Healthcare centers cannot rely on reimbursement policies to cover the entire cost of these devices, further limiting their accessibility to patients who may benefit from them.

Market Trends of the Global Needle-Free Drug Delivery Devices Market

Expansion of Healthcare Applications: A significant trend observed in the market is the broadening scope of drug delivery devices without needles. These devices are now utilized beyond traditional insulin and vaccine delivery, extending to specialized therapeutics and biologics. Technological advancements have facilitated this expansion into additional applications. With the ongoing need for precise and controlled drug administration, further innovations and applications are anticipated in the market.

Rising Demand for Pain-Free Drug Administration: There is a notable shift away from traditional needle-based injections as consumers increasingly prefer needle-free drug delivery devices. This demand for painless options in drug administration is particularly prevalent among patients with chronic illnesses. This shift has spurred the demand for needle-free tools such as transdermal patches and jet injectors, which can deliver medication directly without causing needle-related pain.

Technological Progress: The needle-free drug delivery industry is experiencing continuous technological innovation, a significant market trend. This ongoing innovation has led to major improvements in product design, enhancing precision and usability to ensure patient compliance. Additionally, advancements have enabled these devices to deliver higher volumes or more viscous medications, making them suitable for a wide range of medications and administration needs.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Needle-free Drug Delivery Devices Market by Technology

• Market Overview
• Jet injectors
• Transdermal patches
• and Inhalation-based systems

Global Needle-free Drug Delivery Devices Market by End-user

• Market Overview
• Hospitals and Clinics to Home Healthcare Settings

Global Needle-free Drug Delivery Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zogenix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Medical Products Inc. (NMP Pharma) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmajet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astrazeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImmune (USA, a subsidiary of AstraZeneca)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA, a subsidiary of Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments